SteelPeak Wealth, LLC - XTL BIOPHARMACEUTICALS LTD ownership

XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D307. A total of 6 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SteelPeak Wealth, LLC ownership history of XTL BIOPHARMACEUTICALS LTD
ValueSharesWeighting
Q2 2021$47,000
-2.1%
11,671
-18.8%
0.00%
-25.0%
Q1 2021$48,00014,3750.00%
Other shareholders
XTL BIOPHARMACEUTICALS LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Noked Capital LTD 198,888$551,0000.14%
Noked Israel Ltd 198,888$551,0000.14%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 51,071$141,0000.00%
Tower Research Capital LLC (TRC) 153$00.00%
Renaissance Technologies 23,280$64,0000.00%
UBS Group AG 154$00.00%
View complete list of XTL BIOPHARMACEUTICALS LTD shareholders